Significant control over LTR Pharma by private companies implies that the general public has more power to influence management and governance-related decisions 51% of the business is held by the top ...
The average one-year price target for LIONTOWN RESOURCES (ASX:LTR) has been revised to 1.88 / share. This is an decrease of 9.51% from the prior estimate of 2.08 dated November 26, 2023. The price ...
Every investor in Liontown Resources Limited (ASX:LTR) should be aware of the most powerful shareholder groups. We can see that individual investors own the lion's share in the company with 60% ...
We think all investors should try to buy and hold high quality multi-year winners. While not every stock performs well, when investors win, they can win big. To wit, the Liontown Resources Limited ...
ASX company news and announcements for LTR Pharma Ltd (LTP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All LTR Pharma Ltd (LTP) ASX ...
LTR Pharma (ASX:LTP) has announced a key milestone in the rollout of its nasal spray treatment for erectile dysfunction (ED) with the first select group of patients receiving Spontan under the ...
Liontown Resources (ASX: LTR) shares are down 32%. LTR shares are down on the withdrawal of Albemarle’s (NYSE: ALB) bid for the company. Plus the large rights issue that has now been launched to bring ...
The Liontown (ASX: LTR) share price is trading higher today following the company's announcement of a new CEO. Here's what we know. You’re reading a free article with opinions that may differ from The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback